2m 2m 2m 2m 2m 2m 2m
CELLDEX THERAPTC (CLDX)
NASDAQ
$40.42+$0.03 (+0.09%)
Price as of Aug 21, 2026 7:30 PM EDT- $3.2BMarket Cap
- 79.79%1-Year Change
- BiotechnologyIndustry
CELLDEX THERAPTC (CLDX)
$40.42+$0.03 (+0.09%)
CLDX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $40.38 | ||
Change | +$0.44 (+1.10%) | ||
Open | $40.38 | ||
High | $41.24 | ||
Low | $40.12 | ||
Previous Close | $39.94 | ||
Volume | 837,685 | ||
30-Day Average Volume | 989,190 | ||
1-Week Change | -3.74% | ||
1-Month Change | 13.24% | ||
1-Year Change | 79.79% | ||
3-Year Change | 32.09% | ||
5-Year Change | -15.08% | ||
Fundamentals | |||
Shares Outstanding | 78.5M | ||
Total Assets | $782.3M | ||
Market Cap | $3.2B | ||
Enterprise Value | $3.1B | ||
Period: QTR TTM FY | |||
Revenue | $7,000.00 | ||
Net Income | -$73.5M | ||
Free Cash Flow | -$60.6M | ||
EBIT | -$73.5M | ||
EBITDA | -$72.6M | ||
Net Working Capital | $663.6M | ||
EPS | -$0.94 | ||
Enterprise Value/EBITDA | -43 | ||
Enterprise Value/Revenue | 446,224 | ||
P/B | 4 | ||
P/E | -43 | ||
PEG | -2 | ||
Price/Free Cash Flow | -52 | ||
Price/Operating Cash Flow | -55 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 15 | ||
Last Split Date | 02/11/2019 | ||
Earnings & Revenue